TRPV4 and ovarian carcinoma: TRPV4 is highly expressed in ovarian cancer and is associated with poor prognosis, specifically worse overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and PFS in ovarian cancer [47,48].